Replies to post #213472 on Amarin Corp Plc (AMRN)

[Atom0aks]

On 9-29 the FDA will have taken an action that directly harms 20% of all new Vascepa prescribed patients. 1 out of every 6 of those patients will have an event waiting for the FDA...

Any delay beyond 9-28 is actionable regulatory malpractice, the FDA is not chartered to IGNORE standard of care.

BB

I am not sure where you got those numbers from...